Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Systemic Inflammatory Response Syndrome | 5 | 2023 | 621 | 1.170 |
Why?
|
| Streptococcus pneumoniae | 2 | 2022 | 764 | 0.560 |
Why?
|
| Bacterial Infections | 2 | 2022 | 1390 | 0.510 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2015 | 228 | 0.430 |
Why?
|
| Dengue Virus | 1 | 2015 | 204 | 0.420 |
Why?
|
| Leukocytes | 1 | 2020 | 2034 | 0.400 |
Why?
|
| Dengue | 1 | 2015 | 258 | 0.380 |
Why?
|
| Immunoglobulin M | 1 | 2015 | 1527 | 0.340 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 788 | 0.320 |
Why?
|
| Guideline Adherence | 1 | 2018 | 2232 | 0.290 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 7469 | 0.230 |
Why?
|
| Nepal | 2 | 2022 | 301 | 0.230 |
Why?
|
| Sepsis | 1 | 2018 | 2605 | 0.230 |
Why?
|
| Vaccines, Conjugate | 2 | 2022 | 334 | 0.220 |
Why?
|
| Haemophilus influenzae type b | 1 | 2022 | 16 | 0.200 |
Why?
|
| Meningitis, Pneumococcal | 1 | 2022 | 43 | 0.200 |
Why?
|
| Neisseria meningitidis | 1 | 2022 | 111 | 0.190 |
Why?
|
| Serotyping | 1 | 2022 | 331 | 0.190 |
Why?
|
| Child, Preschool | 7 | 2022 | 42606 | 0.180 |
Why?
|
| Glycocalyx | 1 | 2021 | 99 | 0.180 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 285 | 0.170 |
Why?
|
| Acidosis | 1 | 2021 | 271 | 0.170 |
Why?
|
| Infant | 6 | 2022 | 36485 | 0.150 |
Why?
|
| Coronary Aneurysm | 1 | 2021 | 234 | 0.150 |
Why?
|
| Pneumococcal Vaccines | 1 | 2022 | 414 | 0.150 |
Why?
|
| Fever | 2 | 2016 | 1605 | 0.150 |
Why?
|
| London | 1 | 2018 | 233 | 0.150 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 529 | 0.140 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2021 | 667 | 0.130 |
Why?
|
| Antigens, Bacterial | 1 | 2022 | 1148 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2020 | 1864 | 0.120 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 1969 | 0.120 |
Why?
|
| Videoconferencing | 1 | 2017 | 209 | 0.120 |
Why?
|
| Cambodia | 1 | 2015 | 185 | 0.120 |
Why?
|
| Blood Coagulation | 1 | 2020 | 1163 | 0.110 |
Why?
|
| Child | 8 | 2023 | 80771 | 0.110 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 238 | 0.110 |
Why?
|
| Age of Onset | 1 | 2020 | 3344 | 0.110 |
Why?
|
| Republic of Korea | 1 | 2015 | 591 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2022 | 6067 | 0.100 |
Why?
|
| Information Management | 1 | 2013 | 100 | 0.100 |
Why?
|
| Glucocorticoids | 1 | 2021 | 2163 | 0.100 |
Why?
|
| Antigens | 1 | 2016 | 1442 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 1326 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2016 | 722 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 1481 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 2057 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 12986 | 0.070 |
Why?
|
| Telemedicine | 2 | 2017 | 3110 | 0.070 |
Why?
|
| Immunomodulation | 2 | 2021 | 548 | 0.070 |
Why?
|
| RNA | 1 | 2016 | 2715 | 0.070 |
Why?
|
| Male | 7 | 2022 | 364203 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2017 | 1733 | 0.060 |
Why?
|
| Coronavirus Infections | 1 | 2023 | 3112 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2023 | 3234 | 0.060 |
Why?
|
| Female | 7 | 2022 | 396660 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 89046 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14672 | 0.050 |
Why?
|
| Humans | 12 | 2023 | 767040 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2022 | 12790 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2020 | 22254 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2013 | 2174 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2021 | 41718 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7435 | 0.040 |
Why?
|
| Inflammation | 1 | 2020 | 10869 | 0.040 |
Why?
|
| Heparitin Sulfate | 1 | 2021 | 223 | 0.040 |
Why?
|
| Carrier State | 1 | 2022 | 529 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26396 | 0.040 |
Why?
|
| Prevalence | 1 | 2015 | 15851 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2021 | 54886 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2018 | 24299 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2021 | 1097 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2021 | 2920 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 14098 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 59980 | 0.030 |
Why?
|
| Propensity Score | 1 | 2021 | 1971 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 1639 | 0.020 |
Why?
|
| Organizational Case Studies | 1 | 2013 | 301 | 0.020 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 724 | 0.020 |
Why?
|
| Cost Savings | 1 | 2017 | 904 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6331 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 6310 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2016 | 2602 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2726 | 0.020 |
Why?
|
| Vaccination | 1 | 2022 | 3434 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 3212 | 0.020 |
Why?
|
| Self Care | 1 | 2013 | 800 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2783 | 0.020 |
Why?
|
| Risk | 1 | 2016 | 9606 | 0.010 |
Why?
|
| Logistic Models | 1 | 2016 | 13284 | 0.010 |
Why?
|
| Hospitalization | 1 | 2021 | 10815 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9532 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9360 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15925 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 20741 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 65295 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72971 | 0.010 |
Why?
|
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(3)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_